Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Midatech Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Midatech Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 11
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Midatech Pharma Acquires Zuplenz from Galena Biopharma for up to USD29.7 Million 14
Venture Financing 15
Q Chip Raises US$3 Million Venture Financing 15
Private Equity 16
Kanwa Holdings to Acquire Midatech Pharma US from Midatech Pharma 16
Partnerships 18
Midatech Pharma US Enters into Co-Promotion Agreement with Bausch Health 18
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 19
Midatech Pharma Enters into Agreement with Ophthotech 20
Midatech Pharma Enters into Agreement with Dana-Farber Cancer Institute 21
DARA BioSciences Enters into Commercialization Agreement with Onxeo 22
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 23
Midatech Enters into Research Collaboration Agreement with Middlesex University 24
Dara BioSciences Enters Into Agreement With T3D Therapeutics For DB959 25
Midatech Enters into Research and Collaboration Agreement with The Open University 26
Midatech Enters Into Joint Venture With MonoSol Rx 27
Licensing Agreements 28
Midatech Pharma Enters Into Licensing Agreement with Novartis 28
Emergex Vaccines Enters into Licensing Agreement with Midatech Pharma 29
Helsinn Enters Into Licensing Agreement With Dara BioSciences For Gelclair 30
DARA BioSciences Enters Into Licensing Agreement With Innocutis For Bionect 31
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 32
Equity Offering 33
Midatech Pharma Raises USD8 Million in Private Placement of Shares 33
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 34
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 35
Midatech Pharma Raises USD50 Million in IPO 36
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 38
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 39
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 40
Dara BioSciences Completes Private Placement Of Shares For US$2.6 Million 41
Dara BioSciences Announces Public Offering Of Common Stock For US$2.7 Million 42
Dara BioSciences Completes Private Placement Of Series B-3 Preferred Stock For US$2.6 Million 43
Dara BioSciences Completes Private Placement Of Series B-4 Preferred Stock For US$0.3 Million 44
DARA BioSciences Completes Public Offering Of Units For US$10 Million 45
DARA BioSciences Completes Private Placement Of Preferred Stock For US$1.7 Million 47
Acquisition 49
Midatech Pharma Acquires Dara BioSciences 49
Midatech Pharma Acquires Q Chip 51
DARA BioSciences Acquires Oncogenerix 52
Midatech Pharma Plc – Key Competitors 53
Midatech Pharma Plc – Key Employees 54
Midatech Pharma Plc – Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Joint Venture 55
Recent Developments 56
Strategy And Business Planning 56
Mar 10, 2017: Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility 56
Financial Announcements 57
Apr 23, 2018: Midatech Pharma: Audited financial results for the year ended 31 December 2017 57
Sep 28, 2017: Midatech Pharma: Interim results for the six months ended 30 June 2017 63
Apr 04, 2017: Midatech Pharma Announces Audited financial results for the year ended 31 December 2016 67
Jan 20, 2017: Midatech Pharma Provides Trading Update 68
Corporate Communications 69
Jun 01, 2018: Midatech Pharma: Board change 69
Mar 15, 2018: Midatech announces changes in Senior Management Team 70
Government and Public Interest 71
Nov 23, 2017: Midatech secures manufacturing certification from Spanish regulatory authority 71
Product News 72
May 22, 2017: Midatech announces progress update on brain cancer therapies 72
01/16/2018: Midatech and UCSF receive IND approval for DIPG treatment MTX110 73
Clinical Trials 74
May 25, 2018: Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer 74
Jul 26, 2017: Midatech Pharma: Completion of pre-clinical liver cancer programme 75
Other Significant Developments 76
Jul 25, 2018: Midatech Pharma: Trading update 76
Appendix 77
Methodology 77
About GlobalData 77
Contact Us 77
Disclaimer 77
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Midatech Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Midatech Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 10
Midatech Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 11
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Midatech Pharma Acquires Zuplenz from Galena Biopharma for up to USD29.7 Million 14
Q Chip Raises US$3 Million Venture Financing 15
Kanwa Holdings to Acquire Midatech Pharma US from Midatech Pharma 16
Midatech Pharma US Enters into Co-Promotion Agreement with Bausch Health 18
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 19
Midatech Pharma Enters into Agreement with Ophthotech 20
Midatech Pharma Enters into Agreement with Dana-Farber Cancer Institute 21
DARA BioSciences Enters into Commercialization Agreement with Onxeo 22
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 23
Midatech Enters into Research Collaboration Agreement with Middlesex University 24
Dara BioSciences Enters Into Agreement With T3D Therapeutics For DB959 25
Midatech Enters into Research and Collaboration Agreement with The Open University 26
Midatech Enters Into Joint Venture With MonoSol Rx 27
Midatech Pharma Enters Into Licensing Agreement with Novartis 28
Emergex Vaccines Enters into Licensing Agreement with Midatech Pharma 29
Helsinn Enters Into Licensing Agreement With Dara BioSciences For Gelclair 30
DARA BioSciences Enters Into Licensing Agreement With Innocutis For Bionect 31
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 32
Midatech Pharma Raises USD8 Million in Private Placement of Shares 33
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 34
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 35
Midatech Pharma Raises USD50 Million in IPO 36
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 38
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 39
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 40
Dara BioSciences Completes Private Placement Of Shares For US$2.6 Million 41
Dara BioSciences Announces Public Offering Of Common Stock For US$2.7 Million 42
Dara BioSciences Completes Private Placement Of Series B-3 Preferred Stock For US$2.6 Million 43
Dara BioSciences Completes Private Placement Of Series B-4 Preferred Stock For US$0.3 Million 44
DARA BioSciences Completes Public Offering Of Units For US$10 Million 45
DARA BioSciences Completes Private Placement Of Preferred Stock For US$1.7 Million 47
Midatech Pharma Acquires Dara BioSciences 49
Midatech Pharma Acquires Q Chip 51
DARA BioSciences Acquires Oncogenerix 52
Midatech Pharma Plc, Key Competitors 53
Midatech Pharma Plc, Key Employees 54
Midatech Pharma Plc, Subsidiaries 55
Midatech Pharma Plc, Joint Venture 55
List of Figures
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Midatech Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Midatech Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 11